The Landmarks of OncoPharm series returns to discuss NSABP's B18 story of neoadjuvant vs. adjuvant AC in stages I & II breast cancer from 1998.
B18: https://pubmed.ncbi.nlm.nih.gov/?term=36989610
Flashback Flashforeward: https://pubmed.ncbi.nlm.nih.gov/?term=36989608
